Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light‐based photochemical treatment

BACKGROUND AND OBJECTIVE: Severe acute respiratory distress syndrome coronavirus‐2 (SARS‐CoV‐2), the causative agent of coronavirus disease 2019 (COVID‐19), is a member of the coronavirus family. Coronavirus infections in humans are typically associated with respiratory illnesses; however, viral RNA...

Descripción completa

Detalles Bibliográficos
Autores principales: Keil, Shawn D., Ragan, Izabela, Yonemura, Susan, Hartson, Lindsay, Dart, Nicole K., Bowen, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Transfusion‐transmitted Disease and its Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264728/
https://www.ncbi.nlm.nih.gov/pubmed/32311760
http://dx.doi.org/10.1111/vox.12937

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264728/
https://www.ncbi.nlm.nih.gov/pubmed/32311760
http://dx.doi.org/10.1111/vox.12937

Ejemplares similares